ArticleScientific reports2025
OCT-based diagnosis of glaucoma and glaucoma stages using explainable machine learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Explainable Multimodal OCT and OCTA Analysis Reveals Structural and Vascular Features of Mild Glaucoma Across Ethnicities.Investigative ophthalmology & visual science · 2026Observational
- Image-Quality-Aware Multimodal Artificial Intelligence for Automated Structured OCT Report Generation in Glaucoma Evaluation.Ophthalmology science · 2026Article
- A Lightweight Vision Transformer and Retinal Biomarker Fusion Framework for Early Glaucoma Detection: Toward Improved Clinical Screening.Journal of clinical medicine · 2026Article
- Retinal Ganglion Cell Degeneration in Glaucoma: Systematic Review.Bioengineering (Basel, Switzerland) · 2026Review
- Multiple attention based deep multimodal fusion network for glaucoma and neurodegenerative disease diagnosis.Scientific reports · 2026Article
- Optical coherence tomography alone is insufficient for glaucoma management.Indian journal of ophthalmology · 2026Article
- Predicting HFA 30-2 Visual Fields with Deep Learning from Multimodal OCT-Fundus Feature Fusion and Structure-Function Discordance Analysis.Journal of imaging informatics in medicine · 2026Article
- Recent Advances in AI-Driven Mobile Health Enhancing Healthcare-Narrative Insights into Latest Progress.Bioengineering (Basel, Switzerland) · 2025Review
- Machine learning with multitype functional connectivity uncovers whole-brain network disruption in primary angle-closure glaucoma.Brain informatics · 2025Article
- Glaucoma Detection and Structured OCT Report Generation via a Fine-tuned Multimodal Large Language Model.ArXiv · 2025Article
- Integrating Artificial Intelligence and Precision Therapeutics for Advancing the Diagnosis and Treatment of Age-Related Macular Degeneration.Bioengineering (Basel, Switzerland) · 2025Review
- Research advances on artificial intelligence assisted diagnosis and risk assessment in cardiovascular disease using retinal imaging.Frontiers in cardiovascular medicine · 2025Review
- Multimodal AI diagnostic system for neuromyelitis optica based on ultrawide-field fundus photography.Frontiers in medicine · 2025Article
- Valuable insights into general practice staff's experiences and perspectives on AI-assisted diabetic retinopathy screening-An interview study.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glaucoma poses a growing health challenge projected to escalate in the coming decades. However, current automated diagnostic approaches on Glaucoma diagnosis solely rely on black-box deep learning models, lacking explainability and trustworthiness. To address the issue, this study uses optical coherence tomography (OCT) images to develop an explainable artificial intelligence (XAI) tool for diagnosing and staging glaucoma, with a focus on its clinical applicability. A total of 334 normal and 268 glaucomatous eyes (86 early, 72 moderate, 110 advanced) were included, signal processing theory was employed, and model interpretability was rigorously evaluated. Leveraging SHapley Additive exPlanations (SHAP)-based global feature ranking and partial dependency analysis (PDA) estimated decision boundary cut-offs on machine learning (ML) models, a novel algorithm was developed to implement an XAI tool. Using the selected features, ML models produce an AUC of 0.96 (95% CI: 0.95-0.98), 0.98 (95% CI: 0.96-1.00) and 1.00 (95% CI: 1.00-1.00) respectively on differentiating early, moderate and advanced glaucoma patients. Overall, machine outperformed clinicians in the early stage and overall glaucoma diagnosis with 10.4 -11.2% higher accuracy. The developed user-friendly XAI software tool shows potential as a valuable tool for eye care practitioners, offering transparent and interpretable insights to improve decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.